| DAM, DAM-57 | |
|---|---|
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 295.4 g/mol [1] |
| Predicted LogP | 2.2 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C18H21N3O [1] |
| IUPAC name | (6aR,9R)-N,N,7-trimethyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide [1] |
| SMILES | CN1C[C@@H](C=C2[C@H]1CC3=CNC4=CC=CC2=C34)C(=O)N(C)C [1] |
| InChI | InChI=1S/C18H21N3O/c1-20(2)18(22)12-7-14-13-5-4-6-15-17(13)11(9-19-15)8-16(14)21(3)10-12/h4-7,9,12,16,19H,8,10H2,1-3H3/t12-,16-/m1/s1 [1] |
| InChIKey | FWHSERNVTGTIJE-MLGOLLRUSA-N [1] |
| Toxicity [] | |
|---|---|
| TDLo | Human: - oral: 10 μg/kg |
| LD50 | Rabbit: - intravenous: 400 μg/kg |
Lysergic acid dimethylamide
(Redirected from lysergic acid dimethylamide)Lysergic acid dimethylamide (also known as Lysergic acid dimethylamide, (8β)-9,10-Didehydro-N,N,6-trimethylergoline-8-carboxamide, RefChem:1050739, N,N-Dimethyllysergamide, Dimethyllysergamide, lysergic acid dimethylamide, Ergoline-8-β-carboxamide, 9,10-didehydro-N,N,6-trimethyl-, Lysergamide, N,N-dimethyl-, DAM-57 or (6aR,9R)-N,N,7-trimethyl-6,6a,8,9-tetrahydro-4H-indolo(4,3-fg)quinoline-9-carboxamide) is a psychedelic substance of the lysergamide class.
Chemistry
Stereochemistry []
Lysergic acid dimethylamide is a absolute mixture
Legal status
- United States: Lysergic acid dimethylamide is a Schedule I under the "Controlled Substances Act (CSA)".
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 199478, Lysergic acid dimethylamide. Accessed October 13, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/199478
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Lysergic acid dimethylamide. UNII: LX5MKR2EXX. Global Substance Registration System. Accessed October 13, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/LX5MKR2EXX
Anodyne